European Organization for Research and Treatment of Cancer and International Society for cutaneous lymphoma Consensus recommendations for the management of cutaneous B-cell lymphomas

Nancy J. Senff, Evert M. Noordijk, Youn H. Kim, Martine Bagot, Emilio Berti, Lorenzo Cerroni, Reinhard Dummer, Madeleine Duvic, Richard T. Hoppe, Nicola Pimpinelli, Steven T. Rosen, Maarten H. Vermeer, Sean Whittaker, Rein Willemze

Research output: Contribution to journalArticle

276 Citations (Scopus)

Abstract

Primary cutaneous B-cell lymphomas (CBCL) represent approximately 20% to 25% of all primary cutaneous lymphomas. With the advent of the World Health Organization-European Organization for Research and Treatment of Cancer (EORTC) Consensus Classification for Cutaneous Lymphomas in 2005, uniform terminology and classification for this rare group of neoplasms were introduced. However, staging procedures and treatment strategies still vary between different cutaneous lymphoma centers, which may be because consensus recommendations for the management of CBCL have never been published. Based on an extensive literature search and discussions within the EORTC Cutaneous Lymphoma Group and the International Society for Cutaneous Lymphomas, the present report aims to provide uniform recommendations for the management of the 3 main groups of CBCL. Because no systematic reviews or (randomized) controlled trials were available, these recommendations are mainly based on retrospective studies and small cohort studies. Despite these limitations, there was consensus among the members of the multidisciplinary expert panel that these recommendations reflect the state-of-the-art management as currently practiced in major cutaneous lymphoma centers. They may therefore contribute to uniform staging and treatment and form the basis for future clinical trials in patients with a CBCL 1600-1609)

Original languageEnglish
Pages (from-to)1600-1609
Number of pages10
JournalBlood
Volume112
Issue number5
DOIs
Publication statusPublished - Sep 1 2008

Fingerprint

B-Cell Lymphoma
Lymphoma
Cells
Organizations
Skin
Research
Neoplasms
Terminology
Therapeutics
Health
Skin Neoplasms
Cohort Studies
Randomized Controlled Trials
Retrospective Studies
Clinical Trials

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

European Organization for Research and Treatment of Cancer and International Society for cutaneous lymphoma Consensus recommendations for the management of cutaneous B-cell lymphomas. / Senff, Nancy J.; Noordijk, Evert M.; Kim, Youn H.; Bagot, Martine; Berti, Emilio; Cerroni, Lorenzo; Dummer, Reinhard; Duvic, Madeleine; Hoppe, Richard T.; Pimpinelli, Nicola; Rosen, Steven T.; Vermeer, Maarten H.; Whittaker, Sean; Willemze, Rein.

In: Blood, Vol. 112, No. 5, 01.09.2008, p. 1600-1609.

Research output: Contribution to journalArticle

Senff, NJ, Noordijk, EM, Kim, YH, Bagot, M, Berti, E, Cerroni, L, Dummer, R, Duvic, M, Hoppe, RT, Pimpinelli, N, Rosen, ST, Vermeer, MH, Whittaker, S & Willemze, R 2008, 'European Organization for Research and Treatment of Cancer and International Society for cutaneous lymphoma Consensus recommendations for the management of cutaneous B-cell lymphomas', Blood, vol. 112, no. 5, pp. 1600-1609. https://doi.org/10.1182/blood-2008-04-152850
Senff, Nancy J. ; Noordijk, Evert M. ; Kim, Youn H. ; Bagot, Martine ; Berti, Emilio ; Cerroni, Lorenzo ; Dummer, Reinhard ; Duvic, Madeleine ; Hoppe, Richard T. ; Pimpinelli, Nicola ; Rosen, Steven T. ; Vermeer, Maarten H. ; Whittaker, Sean ; Willemze, Rein. / European Organization for Research and Treatment of Cancer and International Society for cutaneous lymphoma Consensus recommendations for the management of cutaneous B-cell lymphomas. In: Blood. 2008 ; Vol. 112, No. 5. pp. 1600-1609.
@article{54a65a5c18874c8cb0e492b5bd6bd748,
title = "European Organization for Research and Treatment of Cancer and International Society for cutaneous lymphoma Consensus recommendations for the management of cutaneous B-cell lymphomas",
abstract = "Primary cutaneous B-cell lymphomas (CBCL) represent approximately 20{\%} to 25{\%} of all primary cutaneous lymphomas. With the advent of the World Health Organization-European Organization for Research and Treatment of Cancer (EORTC) Consensus Classification for Cutaneous Lymphomas in 2005, uniform terminology and classification for this rare group of neoplasms were introduced. However, staging procedures and treatment strategies still vary between different cutaneous lymphoma centers, which may be because consensus recommendations for the management of CBCL have never been published. Based on an extensive literature search and discussions within the EORTC Cutaneous Lymphoma Group and the International Society for Cutaneous Lymphomas, the present report aims to provide uniform recommendations for the management of the 3 main groups of CBCL. Because no systematic reviews or (randomized) controlled trials were available, these recommendations are mainly based on retrospective studies and small cohort studies. Despite these limitations, there was consensus among the members of the multidisciplinary expert panel that these recommendations reflect the state-of-the-art management as currently practiced in major cutaneous lymphoma centers. They may therefore contribute to uniform staging and treatment and form the basis for future clinical trials in patients with a CBCL 1600-1609)",
author = "Senff, {Nancy J.} and Noordijk, {Evert M.} and Kim, {Youn H.} and Martine Bagot and Emilio Berti and Lorenzo Cerroni and Reinhard Dummer and Madeleine Duvic and Hoppe, {Richard T.} and Nicola Pimpinelli and Rosen, {Steven T.} and Vermeer, {Maarten H.} and Sean Whittaker and Rein Willemze",
year = "2008",
month = "9",
day = "1",
doi = "10.1182/blood-2008-04-152850",
language = "English",
volume = "112",
pages = "1600--1609",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "5",

}

TY - JOUR

T1 - European Organization for Research and Treatment of Cancer and International Society for cutaneous lymphoma Consensus recommendations for the management of cutaneous B-cell lymphomas

AU - Senff, Nancy J.

AU - Noordijk, Evert M.

AU - Kim, Youn H.

AU - Bagot, Martine

AU - Berti, Emilio

AU - Cerroni, Lorenzo

AU - Dummer, Reinhard

AU - Duvic, Madeleine

AU - Hoppe, Richard T.

AU - Pimpinelli, Nicola

AU - Rosen, Steven T.

AU - Vermeer, Maarten H.

AU - Whittaker, Sean

AU - Willemze, Rein

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Primary cutaneous B-cell lymphomas (CBCL) represent approximately 20% to 25% of all primary cutaneous lymphomas. With the advent of the World Health Organization-European Organization for Research and Treatment of Cancer (EORTC) Consensus Classification for Cutaneous Lymphomas in 2005, uniform terminology and classification for this rare group of neoplasms were introduced. However, staging procedures and treatment strategies still vary between different cutaneous lymphoma centers, which may be because consensus recommendations for the management of CBCL have never been published. Based on an extensive literature search and discussions within the EORTC Cutaneous Lymphoma Group and the International Society for Cutaneous Lymphomas, the present report aims to provide uniform recommendations for the management of the 3 main groups of CBCL. Because no systematic reviews or (randomized) controlled trials were available, these recommendations are mainly based on retrospective studies and small cohort studies. Despite these limitations, there was consensus among the members of the multidisciplinary expert panel that these recommendations reflect the state-of-the-art management as currently practiced in major cutaneous lymphoma centers. They may therefore contribute to uniform staging and treatment and form the basis for future clinical trials in patients with a CBCL 1600-1609)

AB - Primary cutaneous B-cell lymphomas (CBCL) represent approximately 20% to 25% of all primary cutaneous lymphomas. With the advent of the World Health Organization-European Organization for Research and Treatment of Cancer (EORTC) Consensus Classification for Cutaneous Lymphomas in 2005, uniform terminology and classification for this rare group of neoplasms were introduced. However, staging procedures and treatment strategies still vary between different cutaneous lymphoma centers, which may be because consensus recommendations for the management of CBCL have never been published. Based on an extensive literature search and discussions within the EORTC Cutaneous Lymphoma Group and the International Society for Cutaneous Lymphomas, the present report aims to provide uniform recommendations for the management of the 3 main groups of CBCL. Because no systematic reviews or (randomized) controlled trials were available, these recommendations are mainly based on retrospective studies and small cohort studies. Despite these limitations, there was consensus among the members of the multidisciplinary expert panel that these recommendations reflect the state-of-the-art management as currently practiced in major cutaneous lymphoma centers. They may therefore contribute to uniform staging and treatment and form the basis for future clinical trials in patients with a CBCL 1600-1609)

UR - http://www.scopus.com/inward/record.url?scp=52649116496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52649116496&partnerID=8YFLogxK

U2 - 10.1182/blood-2008-04-152850

DO - 10.1182/blood-2008-04-152850

M3 - Article

VL - 112

SP - 1600

EP - 1609

JO - Blood

JF - Blood

SN - 0006-4971

IS - 5

ER -